When we think of eczema, we usually associate it with skin conditions. However, recent studies have shown that eczema may have a role in bone fractures as well.

The relationship between eczema and bone health is less explored and understood, but it’s becoming an area of focus for researchers.

Eczema and bone density:

Eczema is a chronic condition that affects the skin, characterized by itchy, red, and dry skin. While it’s generally seen as a skin condition, it can actually have secondary effects on other parts of the body as well.

For example, eczema can result in inflammation throughout the body. This inflammation can impact bone health and cause a loss of bone density.

Bone density is an important factor in protecting against bone fractures. As eczema patients experience a higher incidence of inflammation, they may also be more prone to fractures due to the lost bone density caused by long-term inflammation.

Furthermore, the inflammation that is caused by eczema can also disrupt the normal function of bone metabolism, leading to osteoporosis or osteopenia in some patients.

Calcium and Vitamin D deficiency:

Another way eczema contributes to bone fractures is by causing a deficiency in calcium and Vitamin D. To maintain healthy bones, our bodies need vitamin D and calcium, which are essential for proper bone formation.

Both are nutrients that help bones grow and maintain their structure, and a deficiency in either mineral can lead to bone loss over time.

Unfortunately, eczema patients are more likely to have lower levels of vitamin D, as many patients avoid the sun due to their rashes.

Furthermore, when the skin is inflamed due to eczema, it can lead to significant fluid loss, and this fluid loss can also lead to a decreased concentration of calcium in the blood. These deficiencies can cause bone fragility and increase the risk of fracture, especially if combined with other risk factors like aging.

Eczema treatments:

Eczema treatment must be aggressive to prevent its underlying complications. Severe eczema should be treated, as it could affect bony structures. The use of sunscreen and other sun-protective measures, such as protective clothing, should be encouraged.

Long-term use of phototherapy and calcineurin inhibitors (tacrolimus and pimecrolimus) for eczema treatment is not recommended and can increase the risk of skin cancer, respectively. Instead, using emollients, such as glycerin and hyaluronic acid, is recommended for moisturizing purposes. Moisturizers containing ceramides are great for skin barriers and can decrease the rate of fluid loss on skin inflammations.

Additionally, topical steroid creams are commonly recommended to manage eczema symptoms. However, the long-term use of these creams may also contribute to bone density loss.

Therefore, it’s essential to always seek the advice of a qualified doctor for the safe use of any medication for eczema management.

Conclusion:

The relationship between eczema and bone health is complex and less explored. However, research has shown that eczema may be a risk factor for bone fractures, mainly due to inflammation, low vitamin D, and calcium concentration levels.

It is, therefore, essential for eczema patients to undergo regular bone density testing, obtain adequate levels of vitamin D, and carefully manage inflammation and related eczema therapies to reduce the risk of fractures.